Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-26T12:06:52.608Z Has data issue: false hasContentIssue false
  • English
  • Français

Parkinson's Disease, Multiple Sclerosis and Changes of Residence in Alberta

Published online by Cambridge University Press:  02 December 2014

Nikolaos Yiannakoulias ,
Donald P. Schopflocher ,
Sharon A. Warren  and
Lawrence W. Svenson
Nikolaos Yiannakoulias
Affiliation:
The Public Health Surveillance and Environmental Health, Alberta Health & Wellness School of Geography and Earth Sciences, McMaster University, Hamilton, ON, Canada
Donald P. Schopflocher
Affiliation:
The Public Health Surveillance and Environmental Health, Alberta Health & Wellness Department of Public Health Sciences, University of Alberta Department of Community Health Sciences, University of Calgary, Alberta Institute of Health Economics, Alberta Health & Wellness
Sharon A. Warren
Affiliation:
Multiple Sclerosis Patient Care and Research Clinic, University of Alberta
Lawrence W. Svenson
Affiliation:
The Public Health Surveillance and Environmental Health, Alberta Health & Wellness Department of Public Health Sciences, University of Alberta Department of Community Health Sciences, University of Calgary, Alberta
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Our objective is to examine how persons diagnosed with Multiple Sclerosis (MS) and Parkinson's disease (PD) change residence following disease onset. We hypothesize that persons choose to change residence (locally or regionally) in different ways depending on whether or not they have been diagnosed with MS/PD. We also estimate the effects of residence change on measures of disease prevalence made at several different levels of geography.

Methods:

Using fee-for service and hospitalization data, we identify cases of MS and PD between 1994 and 2004. Both of these case groups are matched to controls based on age, sex, socioeconomic status and municipality of residence. We tabulate and compare the changes of residence among persons in the case and control groups. We also use these data to estimate the effects that changes in residence have on disease prevalence at three different levels of geography.

Results:

Both MS and PD patients were more likely to change residence following disease onset compared to groups of matched controls (p<=0.001). Most changes of residence occur within the same municipality. The total magnitude of these changes is small, however, and is unlikely to affect estimates of disease prevalence; over our study period, the largest change in geographical prevalence estimates due to individual changes in residence was about 1%.

Conclusions:

Persons diagnosed with MS and PD both have mobility characteristics that differ from those of their respective control groups, and in general, are more likely to move to or between Edmonton and Calgary, and less likely to move out of province. However, the balance of mobility characteristics of persons with PD and MS appear unlikely to greatly affect the patterns observed on maps of disease prevalence.

Résumé:

RÉSUMÉ:

Maladie de Parkinson, sclérose en plaques et changements de résidence en Alberta.

Contexte:

L'objectif de cette étude était d'examiner comment les individus chez qui on a posé un diagnostic de sclérose en plaques (SEP) et de maladie de Parkinson (MP) changent de lieu de résidence après le début de la maladie. Notre hypothèse était que les individus choisissent de changer de lieu de résidence (localement ou régionalement) de différentes façons selon qu'ils sont atteints de la SEP ou de la MP. Nous estimons également les effets du changement de lieu de résidence sur la prévalence à différents niveaux géographiques. Méthodes : Nous avons identifié les cas de SEP et de MP entre 1994 et 2004 au moyen des données de paiement à l'acte et d'hospitalisation. Ces deux groupes de patients ont été appariés à des témoins selon l'âge, le sexe, le statut socioéconomique et la municipalité de résidence. Nous avons classifié et comparé les changements de lieu de résidence des individus atteints et des témoins. Nous avons également utilisé ces données pour estimer les effets que les changements de lieu de résidence ont sur la prévalence de la maladie à trois niveaux géographiques différents. Résultats : Les patients atteints de SEP et de MP étaient plus susceptibles de changer de lieu de résidence après le début de la maladie par rapport aux témoins (p ² 0,001). La plupart changeaient de résidence à l'intérieur de la même municipalité. Cependant, ces changements sont peu nombreux et sont peu susceptibles de modifier les estimés de prévalence de la maladie. Pendant notre étude, le changement le plus considérable dans les estimés de prévalence géographique dû changements individuels de lieu de résidence était d'environ 1%. Conclusion : Les individus chez qui on pose un diagnostic de SEP ou de MP ont des caractéristiques de mobilité qui diffèrent de celles de leur groupe témoin respectif et, en général, sont plus susceptibles de déménager à ou entre Edmonton et Calgary et moins susceptibles de déménager hors de la province. Cependant, il semble peu probable que la balance des caractéristiques de mobilité des individus atteints de MP ou de SEP influence de façon importante la cartographie de la prévalence de ces maladies.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 34 , Issue 3 , August 2007 , pp. 343 - 348
Copyright
Copyright © The Canadian Journal of Neurological 2007

References

1. Boyle, P. Population geography: migration and inequalities in mortality and morbidity. Prog Hum Geogr. 2004;28(6):767–76.Google Scholar
2. Bentham, G. Migration and morbidity: implications for geographical studies of disease. Soc Sci Med. 1988;26(1):49–54.CrossRefGoogle ScholarPubMed
3. Lix, LM, Hinds, A, De Verteuil, G, Robinson, JR, Walker, J, Roos, LL. Residential mobility and severe mental illness: a population-based analysis. Adm Policy Ment Health. 2006;33(2):160–71.Google Scholar
4. Lamont, A, Ukoumunne, OC, Tyrer, P, Thornicroft, G, Paterl, R, Slaughter, J. The geographical mobility of severely mentally ill residents of London. Soc Psychiatry Psychiatr Epidemiol. 2000;35(4):164–9.Google Scholar
5. Breslow, RE, Klinger, BI, Erickson, BJ. County drift: a type of geographic mobility of chronic psychiatric patients. Gen Hosp Psychiatry. 1998;20(1):44–7.Google Scholar
6. Rogerson, PA, Han, D. The effects of migration on the detection of geographic differences in disease risk. Soc Sci Med. 2002;55(10):1817–28.Google Scholar
7. Polissar, L. The effect of migration on comparison of disease rates in geographic studies in the United States. Am J Epidemiol. 1980;111(2):175–82.Google Scholar
8. Ellehoj, E, Schopflocher, DP. Calculating small area analysis: definition of sub-regional geographic units in Alberta. Edmonton, Canada: Alberta Health and Wellness, 2003. Available from: http://www.health.gov.ab.ca/resources/publications/pdf/GeosubRHA.pdf.Google Scholar
9. Statistics Canada 2006. Annual Demographic Estimates: Canada, Provinces and Territories 2005-2006. Statistics Canada Catalogue no. 91-215-XIE. Ottawa, September. Available from: http://www.statcan.ca/english/freepub/91-215-XIE/2006000/tablesectionlist.htmGoogle Scholar
10. Statistics, Canada. 2002. Population and Dwelling Counts, for Canada, Provinces, Territories and Census Subdivisions (Municipalities), 2001 and 1996 Censuses, 100% Data. Population and Dwelling Counts. Statistics Canada Catalogue no. 93F0051XIE. Ottawa. June. Available from: http://www12.statcan.ca/english/census01/products/standard/popdwell/tables.cfmGoogle Scholar
11. Warren, S, Warren, K G, Svenson, L W, Schopflocher, D P, Jones, A. Geographic and temporal distribution of mortality rates for Multiple Sclerosis in Canada, 1965-1994. Neuroepidemiology. 2003;22(1):75–81 Google Scholar
12. Svenson, LW, Woodhead, SE, Platt, GH. Regional variations in the prevalence rates of multiple-sclerosis in the province of Alberta, Canada. Neuroepidemiology. 1994;13(1-2):8–13.CrossRefGoogle ScholarPubMed
13. Svenson, LW, Platt, GH, Woodhead, SE. Geographic variations in the prevalence rates of Parkinson’s disease in Alberta. Can J Neurol Sci. 1993;20(4):307–11.Google Scholar
14. Warren, S, Warren, KG (1993). Prevalence, incidence and characteristics of multiple sclerosis in Westlock County, Alberta, Canada. Neurology. 1993;43(9):1760–3.CrossRefGoogle ScholarPubMed
15. Beck, CA, Metz, LM, Svenson, LW, Patten, SB. Regional variation of multiple sclerosis prevalence in Canada. Multiple Sclerosis. 2005;11(5):516–9.CrossRefGoogle ScholarPubMed
16. Oh, JH. Social bonds and the migration intentions of elderly urban residents: the mediating effect of residential satisfaction. Popul Res Policy Rev. 2003;22(2):127–46.CrossRefGoogle Scholar